Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The study aims to evaluate the efficacy and safety of darunavir and cobistastat in the treatment of COVID-19 pneumonia
Description: The diagnosis of critical illness case was based on the notice on printing and distributing the diagnosis and treatment plan of pneumonia with new coronavirus infection (trial version 4) made by National Health Commission of the People's Republic of China.
Measure: The critical illness rate of subjects at weeks 2 Time: 14 days after randomization